Asensus Surgical Dividenda 2024

Detalji o dividendama

Razumevanje dividendnih isplata od Asensus Surgical

Dividende od Asensus Surgical su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od Asensus Surgical tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od Asensus Surgical su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od Asensus Surgical mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

Asensus Surgical Aktienanalyse

Шта ради Asensus Surgical?

Asensus Surgical Inc is a medical technology company based in Research Triangle Park, North Carolina, USA. It was founded in 1995 by Joe Mussallem, who still serves as President and CEO today. Formerly known as "TransEnterix," the company changed its name to Asensus Surgical Inc in 2021 to reflect its commitment to advanced, data-driven surgery. Asensus Surgical Inc aims to revolutionize the way surgical procedures are performed by utilizing robotic technology and offering a wide range of products and services. The company's business model is based on transferring skills typically held by surgeons to robots, with a focus on precision in surgeries. Through the use of machine learning and computer vision, Asensus Surgical Inc allows surgeons to monitor their own movements in real-time on robotic arms in the operating room, leading to significantly more precise work. The company's main division is the Senhance® Surgical System platform. The system consists of three components: the artificial intelligence technology of the Intelligent Surgical Units (ISU), touchscreen consoles, and a further sterilization cabinet. During surgical procedures, the Intelligent Surgical Units process real-time data, enabling improved decision-making during the operation. The touchscreen consoles serve as the user interface, allowing surgeons to monitor and control the operation in real-time on a screen. The sterilization cabinet ensures that the system is sterilized between procedures. In addition to the Senhance® Surgical System platform, Asensus Surgical Inc also offers other innovative products such as disposable instruments. This includes "3-mm instruments," special miniature instruments that can be used through very small incisions in the patient's body. These minimize scarring and enable faster recovery. Another product offered by Asensus Surgical Inc is the AI Camera Assistant, which is based on artificial intelligence (AI). This is a computer software that supports surgeons by analyzing real-time images and enabling monitoring and analysis during the procedure. Combined with the Senhance® Surgical System, the AI Camera Assistant allows for more precise and safer work. Asensus Surgical Inc has achieved several significant milestones in its history. One of these milestones is the FDA approval of the Senhance® Surgical System platform in 2017. Furthermore, in 2020, the company entered into an agreement with Johnson & Johnson to advance the marketing of products. Overall, Asensus Surgical Inc is an emerging company in the highly innovative field of robotics in surgery. With its advanced products and focus on precise, safe, and straightforward surgery, the company will continue to play an important role in the healthcare industry, saving and improving lives. Asensus Surgical je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o Asensus Surgical akciji

Kolika je dividenda koju isplaćuje Asensus Surgical?

U poslednjih 12 meseci, Asensus Surgical je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Asensus Surgical će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Asensus Surgical?

Dividendski prinos od Asensus Surgical trenutno iznosi .

Kada Asensus Surgical isplaćuje dividendu?

Asensus Surgical isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Asensus Surgical?

Asensus Surgical je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Asensus Surgical?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Asensus Surgical?

Asensus Surgical se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Asensus Surgical kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Asensus Surgical od 19. 9. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 19. 9. 2024..

Kada je Asensus Surgical poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 19. 9. 2024..

Kolika je bila dividenda od Asensus Surgical u godini 2023?

U godini 2023 kompanija Asensus Surgical je isplatila 0 USD kao dividende.

U kojoj valuti Asensus Surgical isplaćuje dividendu?

Dividende od Asensus Surgical se isplaćuju u USD.